Dual degradation signals control Gli protein stability and tumor formation

Program in Epithelial Biology, Stanford University, Stanford, California 94305, USA.
Genes & Development (Impact Factor: 12.64). 03/2006; 20(3):276-81. DOI: 10.1101/gad.1380906
Source: PubMed

ABSTRACT Regulated protein destruction controls many key cellular processes with aberrant regulation increasingly found during carcinogenesis. Gli proteins mediate the transcriptional effects of the Sonic hedgehog pathway, which is implicated in up to 25% of human tumors. Here we show that Gli is rapidly destroyed by the proteasome and that mouse basal cell carcinoma induction correlates with Gli protein accumulation. We identify two independent destruction signals in Gli1, D(N) and D(C), and show that removal of these signals stabilizes Gli1 protein and rapidly accelerates tumor formation in transgenic animals. These data argue that control of Gli protein accumulation underlies tumorigenesis and suggest a new avenue for antitumor therapy.

Download full-text


Available from: Erik Huntzicker, Jul 29, 2015
  • Source
    • "and CK1 dependent phosphory- lation Huntzicker et al., 2006 Indirect through HDAC "
    [Show abstract] [Hide abstract]
    ABSTRACT: The Hedgehog (Hh) signaling pathway plays crucial roles both in embryonic development and in adult stem cell function. The timing, duration and location of Hh signaling activity need to be tightly controlled. Abnormalities of Hh signal transduction lead to birth defects or malignant tumors. Recent data point to ubiquitination-related posttranslational modifications of several key Hh pathway components as an important mechanism of regulation of the Hh pathway. Here we review how ubiquitination regulates the localization, stability and activity of the key Hh signaling components.
    01/2015; DOI:10.1007/s11515-015-1343-5
  • Source
    • "Shh target gene induction occurs in both the epithelium and the underlying DC, suggesting that reception of Shh signaling occurs in both compartments. Epidermal-specific gainof-function studies of Shh or pathway mediators, Gli1, Gli2, and Smoothened (Smo), demonstrate that the epithelial role of Shh signaling in the early hair follicle epithelium is to drive epithelial proliferation (Dahmane et al. 1997; Xie et al. 1998; Grachtchouk et al. 2000; Huntzicker et al. 2006). "
    [Show abstract] [Hide abstract]
    ABSTRACT: During hair follicle morphogenesis, dermal papillae (DPs) function as mesenchymal signaling centers that cross-talk with overlying epithelium to regulate morphogenesis. While the DP regulates hair follicle formation, relatively little is known about the molecular basis of DP formation. The morphogen Sonic hedgehog (Shh) is known for regulating hair follicle epithelial growth, with excessive signaling resulting in basal cell carcinomas. Here, we investigate how dermal-specific Shh signaling contributes to DP formation and hair growth. Using a Cre-lox genetic model and RNAi in hair follicle reconstitution assays, we demonstrate that dermal Smoothened (Smo) loss of function results in the loss of the DP precursor, the dermal condensate, and a stage 2 hair follicle arrest phenotype reminiscent of Shh(-/-) skin. Surprisingly, dermal Smo does not regulate cell survival or epithelial proliferation. Rather, molecular screening and immunostaining studies reveal that dermal Shh signaling controls the expression of a subset of DP-specific signature genes. Using a hairpin/cDNA lentiviral system, we show that overexpression of the Shh-dependent gene Noggin, but not Sox2 or Sox18, can partially rescue the dermal Smo knockdown hair follicle phenotype by increasing the expression of epithelial Shh. Our findings suggest that dermal Shh signaling regulates specific DP signatures to maintain DP maturation while maintaining a reciprocal Shh-Noggin signaling loop to drive hair follicle morphogenesis.
    Genes & development 06/2012; 26(11):1235-46. DOI:10.1101/gad.187401.112 · 12.64 Impact Factor
  • Source
    • "Further deletion of residues 51– 116 on the N-terminus of GLI1 resulted in further stabilization beyond that provided by deletion of the C-terminal degrons signal indicating an N-terminal degron was likely present. However, the N-terminal degrons signals were not affected by βTrCP or by SUFU suggesting an alternative method of degradation by this degron signal (Huntzicker et al., 2006). The importance of GLI1 protein stability controlled by these degron signals was illustrated in this same study by mice expressing GLI1 mutants. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Glioma-associated oncogene homolog 1 (GLI1) is the nuclear mediator of Hedgehog signaling that activates gene transcription via its zinc finger DNA-binding and transactivation domains. GLI1 plays a critical role in several cellular processes, including embryonic development, tumorigenesis, and tumor growth and progression. The human GLI1 gene was identified in 1987 as an amplified gene in glioblastoma. Somatic mutations have never been reported in the GLI1 gene in any cell or tumor type. Very recently in 2008-2009, the full-length GLI1 transcript was discovered to undergo alternative splicing to form two shorter isoforms, namely N-terminal deletion variant (GLI1ΔN) and truncated GLI1 (tGLI1). Emerging evidence suggests that the three structurally different GLI1 isoforms are distinctly different in their expression patterns and functions in the context of human cancers. The tGLI1 isoform, in particular, has been shown to gain the ability to modulate expression of the genes that are not regulated by GLI1 and to support the biology of more aggressive cancer. Consequently, a key focus of this chapter is to summarize and compare the properties of the three GLI1 isoforms and their relations to malignant biology of human cancers.
    Vitamins & Hormones 01/2012; 88:115-40. DOI:10.1016/B978-0-12-394622-5.00006-7 · 1.78 Impact Factor
Show more